clarus

CRYPTOCOCCAL ANTIGEN ENZYME IMMUNOASSAY

It's About

TIME

Cryptococcal meningitis is one of the most common opportunistic infections among HIV/AIDS patients, estimating more than 220,000 cases and 181,000 deaths worldwide each year.1 Early detection and treatment of infection are key to reducing the mortality associated with this disease.

This test is a direct immunoenzymatic, sandwich microplate assay and has been considered the most sensitive and specific EIA for the detection of cryptococcal antigen.

1) Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873-881.

: Serum, CSF
FDA : Serum, CSF
Results in

2 HOURS

Reduce Sendouts
Reduce

SEND-OUT TESTING

Accuracy
Highly

SENSITIVE & SPECIFIC

Clinical Relevancy2

Competitor EIA Positive % Agreement Negative % Agreement
Serum 98.5% 97.7%
CSF 93.5% 99.2%
2.IMMY CRY101 IFU
Cryptococcus Antigen EIA 192 tests CRY101